1. Home
  2. IRIX vs KALA Comparison

IRIX vs KALA Comparison

Compare IRIX & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRIX
  • KALA
  • Stock Information
  • Founded
  • IRIX 1989
  • KALA 2009
  • Country
  • IRIX United States
  • KALA United States
  • Employees
  • IRIX N/A
  • KALA N/A
  • Industry
  • IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • KALA Biotechnology: Pharmaceutical Preparations
  • Sector
  • IRIX Health Care
  • KALA Health Care
  • Exchange
  • IRIX Nasdaq
  • KALA Nasdaq
  • Market Cap
  • IRIX 22.4M
  • KALA 26.2M
  • IPO Year
  • IRIX 1996
  • KALA 2017
  • Fundamental
  • Price
  • IRIX $1.30
  • KALA $18.75
  • Analyst Decision
  • IRIX
  • KALA Strong Buy
  • Analyst Count
  • IRIX 0
  • KALA 3
  • Target Price
  • IRIX N/A
  • KALA $25.00
  • AVG Volume (30 Days)
  • IRIX 86.5K
  • KALA 282.2K
  • Earning Date
  • IRIX 11-11-2025
  • KALA 11-11-2025
  • Dividend Yield
  • IRIX N/A
  • KALA N/A
  • EPS Growth
  • IRIX N/A
  • KALA N/A
  • EPS
  • IRIX N/A
  • KALA N/A
  • Revenue
  • IRIX $49,744,000.00
  • KALA N/A
  • Revenue This Year
  • IRIX $9.61
  • KALA N/A
  • Revenue Next Year
  • IRIX N/A
  • KALA N/A
  • P/E Ratio
  • IRIX N/A
  • KALA N/A
  • Revenue Growth
  • IRIX 0.09
  • KALA N/A
  • 52 Week Low
  • IRIX $0.78
  • KALA $2.92
  • 52 Week High
  • IRIX $2.04
  • KALA $20.00
  • Technical
  • Relative Strength Index (RSI)
  • IRIX 50.65
  • KALA 80.26
  • Support Level
  • IRIX $1.31
  • KALA $13.14
  • Resistance Level
  • IRIX $1.47
  • KALA $15.66
  • Average True Range (ATR)
  • IRIX 0.07
  • KALA 1.87
  • MACD
  • IRIX -0.01
  • KALA 0.49
  • Stochastic Oscillator
  • IRIX 16.25
  • KALA 83.48

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Share on Social Networks: